Vect Horus a reçu l’accord de la Région Sud Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de 1 146 069 €.
Vect-Horus développe sa plateforme technologique VECTrans® unique en Europe dont l’objectif est de développer des molécules « vecteurs » qui permettent le ciblage et la délivrance d’agents d’imagerie ou thérapeutiques dans des organes spécifiques. Cette stratégie est centrale, en (…)
Home > Keywords > Thématique > Agenda
Agenda
Articles
-
FEDER
16 March 2022, by Jonathan NOWAK -
Happy new year !
24 December 2021, by Elodie DORMESThe Vect-Horus teams join to wish you a Happy Holiday season and Best Wishes for 2022.
-
e-Meet Vect-Horus at the digital BIO Europe Spring from March 28 to 31, 2022
15 March 2022, by Elodie DORMESEmmanuelle BETTENDORF will participate in BioEurope Spring from March 28 to 31, 2022 and will be available to meet with you on partnership opportunities.
-
Vect-Horus will be attending BIO Europe from the 24th - 26th October in Germany
20 October 2022, by Elodie DORMESThis is the first in person BIOEurope since 2019 and we are excited to meet everyone face-to-face again.
Feel free to connect with Emmanuelle BETTENDORF on the platform for a meeting/coffee to discuss our DrugDelivery platform, amongt others in Neurodegenerative, Muscular, Cardiovascular and Eye diseases. -
Meet Vect-Horus at BIO Japan, October 8-10, 202
19 September 2025, by Emmanuelle BETTENDORFWe are excited to be attending BioJapan, taking place October 8-10.
Our Senior Business Developer Faustine Ramel will be in Yokohama for the event – please let us know if you would like to schedule a meeting.
https://jcd-expo.jp/en/ -
Meet Vect-Horus at BIO International
26 May 2021, by Elodie DORMESElodie DORMES will attend Bio International Convention in June 10-18, 2021.
-
Selected for a 5’ Pitch at the 2nd edition of the TOULOUSE ONCO WEEK
28 January 2019, by Jonathan NOWAKCédric MALICET, PhD Oncology Project Manager, will present VECT-HORUS’ proprietary technology platform, VECTrans®, that facilitates the targeted delivery of imaging or therapeutic agents to tumors using receptor mediated transport.
http://www.toulouse-onco-week.org/index.php?langue=en&onglet=0&acces=&idUser=&emailUser= -
Meet Vect-Horus at BIO Europe Copenhagen
28 January 2019, by Jonathan NOWAKVECT-HORUS will attend BIO Europe from 5–7 November 2018.
If you are interested to meet, please use the B2B Partnering system. -
8th Edition of BioFIT for the first time in MARSEILLE
4 December 2019, by Elodie DORMESVect-Horus will be present at the BioFIT partnering event on December 10th, 2019 in Marseille.
-
CNS Barrier Congress
28 January 2019, by Jonathan NOWAK22-23 March 2017 // Holiday Inn London Kensington Hotel